Michael Tsatsaronis is the CEO of Primepharm, based in Athens, Greece.
Since 2017, he has covered various roles within the company’s Strategic and Operations planning functions.
In 2019, he was appointed as the company’s CEO.
In 2023, he was elected as the Vice President of the Panhellenic Association of Pharmaceutical Wholesalers.
He holds a BSc in Business Administration: Management from Northeastern University and a MSc in Enterprise Risk Management: Finance from Columbia University.